NSC 86429
CAS No. 5812-07-7
NSC 86429( SU-4312 | SU 4312 | SU4312. DMBI | NSC 86429 )
Catalog No. M17109 CAS No. 5812-07-7
SU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 42 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 125 | In Stock |
|
| 25MG | 232 | In Stock |
|
| 50MG | 363 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSC 86429
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively).
-
DescriptionSU-4312, also known as DMBI, is a potent and selective inhibitor of VEGFR and PDGFR tyrosine kinases (IC50 values are 0.8 and 19.4 μM respectively). SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS.
-
In VitroReceptor tyrosine kinases (RTKs) have been shown to be important mediators of cellular signal transduction in cells. Many RTKs have been shown to be oncogene products implicating their role in the transformation process associated with human cancers.
-
In Vivo——
-
SynonymsSU-4312 | SU 4312 | SU4312. DMBI | NSC 86429
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetAkt
-
RecptorPDGFR| VEGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number5812-07-7
-
Formula Weight264.33
-
Molecular FormulaC17H16N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (189.16 mM)
-
SMILESCN(C)C1=CC=C(C=C1)/C=C\2/C3=CC=CC=C3NC2=O
-
Chemical Name3-[[4-(dimethylamino)phenyl]methylene]-1,3-dihydro-2H-indol-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Li Y, et al. Vascular Endothelial Growth Factor-A (VEGF-A) Mediates Activin A-Induced Human Trophoblast Endothelial-Like Tube Formation. Endocrinology. 2015 Nov;156(11):4257-68.
molnova catalog
related products
-
SC-79
A unique specific Akt activator; binds to the PH domain of Akt and inhibits Akt membrane translocation.
-
M2698
M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity.
-
Hu7691 free base
Hu7691 free base is an orally active, potent, and selective Akt inhibitor with anti-proliferative and neurogenic effects on various neuroblastoma cell lines.
Cart
sales@molnova.com